Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Genome-based Drug Discovery

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1739224

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1739224

Protein Chips

PUBLISHED:
PAGES: 216 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Protein Chips Market to Reach US$3.4 Billion by 2030

The global market for Protein Chips estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Analytical Microarrays, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Functional Protein Microarrays segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$633.4 Million While China is Forecast to Grow at 6.0% CAGR

The Protein Chips market in the U.S. is estimated at US$633.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$552.8 Million by the year 2030 trailing a CAGR of 6.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.4% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global "Protein Chips" Market - Is the Future of Diagnostics and Drug Discovery Encoded in Proteomics?

Is the Push Toward Precision Medicine Accelerating Protein Chip Adoption?

As the healthcare industry pivots toward precision medicine, protein chips-also known as protein microarrays-are becoming essential tools for high-throughput analysis of protein interactions, expression patterns, and disease biomarkers. These chips allow for the simultaneous quantification of thousands of proteins, aiding in early disease detection, patient stratification, and targeted drug development. Researchers and diagnostic labs are increasingly relying on protein chips to complement genomics, offering a more functional snapshot of disease mechanisms. In oncology, autoimmune disorders, and infectious diseases, protein chips are helping identify novel therapeutic targets and validate treatment efficacy at the molecular level. As clinical trials demand more robust biomarker profiling, the role of proteomics-and by extension, protein chips-is expanding within both academic and commercial R&D pipelines.

Are Technological Advancements Making Protein Chips More Accessible and Scalable?

The evolution of microarray fabrication and detection technologies is enhancing the performance, affordability, and reproducibility of protein chips. Advances in surface chemistry, laser scanning, and fluorescence detection are allowing researchers to achieve greater sensitivity and dynamic range. The integration of machine learning and AI into data analysis platforms is also streamlining interpretation and biomarker discovery. As automation becomes commonplace in life sciences labs, protein chip workflows are being integrated into robotic systems for sample handling and reagent delivery, increasing throughput and reproducibility. Additionally, portable and multiplexed devices are emerging for point-of-care diagnostics, enabling protein chip utility outside of centralized labs. These innovations are positioning protein chips not just as research tools, but as potential clinical diagnostics platforms.

Is the Application Landscape Widening Beyond Traditional Research?

Protein chips are now finding applications beyond basic research and drug discovery, including agricultural biotechnology, environmental testing, and personalized nutrition. In agriculture, for example, protein microarrays are being used to detect plant pathogens and optimize crop resistance. In environmental health, protein chips can monitor exposure to toxins by analyzing changes in protein expression. Personalized nutrition companies are exploring proteomic profiling to recommend diet and lifestyle adjustments tailored to metabolic needs. Academic institutions, CROs, and pharmaceutical firms remain primary users, but startups and consumer health tech companies are beginning to adopt this technology to offer individualized wellness insights. As the cost of protein chips declines, more industries are recognizing their diagnostic and analytical potential.

The Growth in the Protein Chips Market Is Driven by Several Factors…

The growth in the protein chips market is driven by several factors stemming from advancements in microarray technology, broader end-use applications, and increased demand for personalized medicine. Technologically, innovations in signal detection, miniaturization, and chip reproducibility are making protein chips more powerful and accessible. End-use growth is seen in pharmaceutical R&D, molecular diagnostics, and point-of-care testing, where fast and multiplexed protein analysis is critical. Consumers-especially in wellness and genomics-are also driving demand for individualized proteomic data, supporting use cases in preventive healthcare. Further, the expansion of proteomics infrastructure in Asia-Pacific and increased public-private research funding are contributing to the global scaling of protein chip manufacturing and adoption. These converging trends are establishing protein chips as a linchpin technology in modern biomedical research and diagnostics.

SCOPE OF STUDY:

The report analyzes the Protein Chips market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays, Other Types); Application (Antibody Characterization, Clinical Diagnostics, Proteomics, Other Applications); Detection Technique (Fluorescence, Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques); End-User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abcam plc
  • Agilent Technologies Inc.
  • Arrayit Corporation
  • Ayoxxa Biosystems GmbH
  • Bio-Rad Laboratories Inc.
  • CDI Laboratories Inc.
  • Danaher Corporation
  • Full Moon BioSystems Inc.
  • Illumina Inc.
  • Innopsys S.A.
  • Luminex Corporation
  • Microarrays Inc.
  • OriGene Technologies Inc.
  • PerkinElmer Inc.
  • RayBiotech Inc.
  • Roche Diagnostics
  • Sengenics Corporation Pte Ltd.
  • Shimadzu Corporation
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP34264

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Protein Chips - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Focus on Personalized Medicine Propels Demand for High-Throughput Protein Analysis
    • Growth in Biomarker Discovery and Disease Profiling Expands Applications in Oncology and Neurology
    • Rising Adoption of Multiplexed Assays Accelerates Use in Drug Development Pipelines
    • Integration of AI and Machine Learning Enhances Data Interpretation and Diagnostic Accuracy
    • Expansion of Proteomics Research in Academic Institutions Drives Product Demand
    • Technological Advancements in Microarray Surface Chemistry Strengthen Analytical Performance
    • Growing Prevalence of Chronic Diseases Spurs Use of Protein Chips in Clinical Diagnostics
    • Miniaturization and Automation of Laboratory Processes Propel Adoption in Research Settings
    • Government Funding for Life Sciences R&D Supports Market Growth Across Developed Nations
    • Partnerships Between Biotech Firms and CROs Increase Commercialization of Custom Protein Arrays
    • Increased Interest in Immune Profiling and Vaccine Development Boosts Segment Demand
    • Shift Toward Point-of-Care Diagnostics Expands Use of Lab-on-a-Chip Solutions
    • Rising Throughput Requirements in Genomic-Proteomic Integration Strengthens Market Appeal
    • Emergence of Next-Gen Antibody-Based Chips Drives Innovation and Competitive Differentiation
    • Regulatory Advancements and Approval Pathways Facilitate Clinical Use of Protein Microarrays
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Protein Chips Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Protein Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Protein Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Analytical Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Analytical Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Functional Protein Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Functional Protein Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Reverse Phase Protein Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Reverse Phase Protein Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Chemiluminescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Chemiluminescence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Electrical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Electrical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other Detection Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other Detection Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Fluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Fluorescence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Antibody Characterization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Antibody Characterization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Protein Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Protein Chips by Type - Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Protein Chips by Type - Percentage Breakdown of Value Sales for Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Protein Chips by Detection Technique - Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Protein Chips by Detection Technique - Percentage Breakdown of Value Sales for Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Protein Chips by End-user - Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Protein Chips by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies for the Years 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Protein Chips by Application - Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for Protein Chips by Application - Percentage Breakdown of Value Sales for Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Protein Chips by Type - Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Protein Chips by Type - Percentage Breakdown of Value Sales for Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Protein Chips by Detection Technique - Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Protein Chips by Detection Technique - Percentage Breakdown of Value Sales for Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Protein Chips by End-user - Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Protein Chips by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Protein Chips by Application - Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Protein Chips by Application - Percentage Breakdown of Value Sales for Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Protein Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Protein Chips by Type - Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Protein Chips by Type - Percentage Breakdown of Value Sales for Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Protein Chips by Detection Technique - Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Protein Chips by Detection Technique - Percentage Breakdown of Value Sales for Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Protein Chips by End-user - Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Protein Chips by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Protein Chips by Application - Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Protein Chips by Application - Percentage Breakdown of Value Sales for Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications for the Years 2025 & 2030
  • CHINA
    • Protein Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Protein Chips by Type - Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Protein Chips by Type - Percentage Breakdown of Value Sales for Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Protein Chips by Detection Technique - Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Protein Chips by Detection Technique - Percentage Breakdown of Value Sales for Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Protein Chips by End-user - Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Protein Chips by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Protein Chips by Application - Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Protein Chips by Application - Percentage Breakdown of Value Sales for Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Protein Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Protein Chips by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Protein Chips by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Protein Chips by Type - Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Protein Chips by Type - Percentage Breakdown of Value Sales for Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Protein Chips by Detection Technique - Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Protein Chips by Detection Technique - Percentage Breakdown of Value Sales for Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Protein Chips by End-user - Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Protein Chips by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Protein Chips by Application - Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Protein Chips by Application - Percentage Breakdown of Value Sales for Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Protein Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Protein Chips by Type - Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Protein Chips by Type - Percentage Breakdown of Value Sales for Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Protein Chips by Detection Technique - Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Protein Chips by Detection Technique - Percentage Breakdown of Value Sales for Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Protein Chips by End-user - Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Protein Chips by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Protein Chips by Application - Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Protein Chips by Application - Percentage Breakdown of Value Sales for Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Protein Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Protein Chips by Type - Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Protein Chips by Type - Percentage Breakdown of Value Sales for Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Protein Chips by Detection Technique - Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Protein Chips by Detection Technique - Percentage Breakdown of Value Sales for Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence for the Years 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Protein Chips by End-user - Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Protein Chips by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies for the Years 2025 & 2030
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Protein Chips by Application - Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for Protein Chips by Application - Percentage Breakdown of Value Sales for Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Protein Chips by Type - Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Protein Chips by Type - Percentage Breakdown of Value Sales for Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Protein Chips by Detection Technique - Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Protein Chips by Detection Technique - Percentage Breakdown of Value Sales for Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence for the Years 2025 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Protein Chips by End-user - Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Italy 6-Year Perspective for Protein Chips by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies for the Years 2025 & 2030
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Protein Chips by Application - Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for Protein Chips by Application - Percentage Breakdown of Value Sales for Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Protein Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Protein Chips by Type - Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Protein Chips by Type - Percentage Breakdown of Value Sales for Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Protein Chips by Detection Technique - Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Protein Chips by Detection Technique - Percentage Breakdown of Value Sales for Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence for the Years 2025 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Protein Chips by End-user - Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: UK 6-Year Perspective for Protein Chips by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies for the Years 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Protein Chips by Application - Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK 6-Year Perspective for Protein Chips by Application - Percentage Breakdown of Value Sales for Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Protein Chips by Type - Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Protein Chips by Type - Percentage Breakdown of Value Sales for Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Protein Chips by Detection Technique - Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Protein Chips by Detection Technique - Percentage Breakdown of Value Sales for Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence for the Years 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Protein Chips by End-user - Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 6-Year Perspective for Protein Chips by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies for the Years 2025 & 2030
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Protein Chips by Application - Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 6-Year Perspective for Protein Chips by Application - Percentage Breakdown of Value Sales for Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Protein Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Protein Chips by Type - Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Protein Chips by Type - Percentage Breakdown of Value Sales for Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Protein Chips by Detection Technique - Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Protein Chips by Detection Technique - Percentage Breakdown of Value Sales for Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence for the Years 2025 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Protein Chips by End-user - Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 6-Year Perspective for Protein Chips by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies for the Years 2025 & 2030
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Protein Chips by Application - Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 6-Year Perspective for Protein Chips by Application - Percentage Breakdown of Value Sales for Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Protein Chips by Type - Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Protein Chips by Type - Percentage Breakdown of Value Sales for Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays and Other Types for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Protein Chips by Detection Technique - Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Protein Chips by Detection Technique - Percentage Breakdown of Value Sales for Chemiluminescence, Mass Spectrometry, Electrical, Other Detection Techniques and Fluorescence for the Years 2025 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for Protein Chips by End-user - Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of World 6-Year Perspective for Protein Chips by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies for the Years 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Protein Chips by Application - Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World 6-Year Perspective for Protein Chips by Application - Percentage Breakdown of Value Sales for Antibody Characterization, Clinical Diagnostics, Proteomics and Other Applications for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!